...
首页> 外文期刊>Endocrinology and Metabolism Clinics of North America >Update on differentiated thyroid cancer staging
【24h】

Update on differentiated thyroid cancer staging

机译:分化型甲状腺癌分期的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

In this review, we demonstrate how initial estimates of the risk of disease-specific mortality and recurrent/persistent disease should be used to guide initial treatment recommendations and early management decisions and to set appropriate patient expectations with regard to likely outcomes after initial therapy of thyroid cancer. The use of ongoing risk stratification to modify these initial risk estimates is also discussed. Novel response to therapy definitions are proposed that can be used for ongoing risk stratification in thyroid cancer patients treated with lobectomy or total thyroidectomy without radioactive iodine remnant ablation.
机译:在本综述中,我们证明应如何使用疾病特异性死亡率和复发/持续性疾病风险的初始估计值来指导初始治疗建议和早期治疗决策,并就甲状腺初始治疗后可能的结果设定适当的患者期望癌症。还讨论了使用进行中的风险分层来修改这些初始风险估计。提出了对治疗定义的新反应,可将其用于未接受放射性碘残留消融的经肺叶切除术或全甲状腺切除术治疗的甲状腺癌患者的持续危险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号